6.1

CVE-2017-17678

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
Bmc ≫ Remedy Mid-tier Version9.1 Updatesp3
Zu dieser CVE wurde keine Warnung gefunden.
EPSS Metriken
Typ Quelle Score Percentile
EPSS FIRST.org 0.85% 0.531
CVSS Metriken
Quelle Base Score Exploit Score Impact Score Vector String
nvd@nist.gov 6.1 2.8 2.7
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
nvd@nist.gov 4.3 8.6 2.9
AV:N/AC:M/Au:N/C:N/I:P/A:N
CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.

http://bmc.com
Product
http://remedy.com
Product
https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
Vendor Advisory
Release Notes
https://seclists.org/fulldisclosure/2017/Oct/52
Third Party Advisory
Mailing List